Time to reconsider risk for psychosis?
Brain · 03.08.2026 · 149 (8) · 2562-2563
DOI: 10.1093/brain/awag230 ↗Kurz gefasst
Kommentar in der Zeitschrift Brain, online erschienen am 30.06.2026. Verfasst von Stefan Kaiser und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Geneva University Hospitals, 1226 Thônex, Switzerland. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Swiss National Science Foundation, Wyss Center Geneva.
Abstract (Originalsprache)
This scientific commentary refers to ‘Biosignatures of cognitive basic symptoms mark a distinct neurodevelopmental pathway to schizophrenia’ by Koutsouleris et al. (https://doi.org/10.1093/brain/awag100).
Autor:innen und Institutionen
- Department of Psychiatry, Geneva University Hospitals, 1226 Thônex, Switzerland.
- Synapsy Center for Neuroscience and Mental Health Research, Faculty of Medicine, University of Geneva, 1202 Geneva, Switzerland.
Förderung
- Swiss National Science Foundation
- Wyss Center Geneva
Zitieren
APA
Kaiser, S., & Kirschner, M. (2026). Time to reconsider risk for psychosis?. Brain, 149(8), 2562-2563. https://doi.org/10.1093/brain/awag230
Vancouver
Kaiser S, Kirschner M. Time to reconsider risk for psychosis?. Brain. 2026;149(8):2562-2563. doi:10.1093/brain/awag230
BibTeX
@article{Kaiser2026,
author = {Kaiser, Stefan and Kirschner, Matthias},
title = {Time to reconsider risk for psychosis?},
journal = {Brain},
year = {2026},
volume = {149},
number = {8},
pages = {2562--2563},
doi = {10.1093/brain/awag230}
}
EUVIMED